Netrin-1 acts as a survival factor for aggressive neuroblastoma

Author:

Delloye-Bourgeois Céline1,Fitamant Julien1,Paradisi Andrea1,Cappellen David2,Douc-Rasy Setha2,Raquin Marie-Anne2,Stupack Dwayne3,Nakagawara Akira4,Rousseau Raphaël5,Combaret Valérie5,Puisieux Alain5,Valteau-Couanet Dominique2,Bénard Jean2,Bernet Agnès1,Mehlen Patrick1

Affiliation:

1. Apoptosis, Cancer and Development Laboratory, Equipe labellisée ‘La Ligue’, Centre National de la Recherche Scientifique UMR5238, Université de Lyon, 69008 Lyon, France

2. Molecular Interactions and Cancer Centre, National de la Recherche Scientifique UMR 8126 and IFR54, and Oncopediatric Department, Gustave Roussy Institute, 94805 Villejuif Cedex, France

3. Department of Pathology, School of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093

4. Division of Biochemistry, Chiba Cancer Center Research Institute, Chiba 260-8717, Japan

5. Institut National de la Santé et de la Recherche Médicale U590, Unité d'Oncologie Moléculaire, Université de Lyon, 69008 Lyon, France

Abstract

Neuroblastoma (NB), the most frequent solid tumor of early childhood, is diagnosed as a disseminated disease in >60% of cases, and several lines of evidence support the resistance to apoptosis as a prerequisite for NB progression. We show that autocrine production of netrin-1, a multifunctional laminin-related molecule, conveys a selective advantage in tumor growth and dissemination in aggressive NB, as it blocks the proapoptotic activity of the UNC5H netrin-1 dependence receptors. We show that such netrin-1 up-regulation is a potential marker for poor prognosis in stage 4S and, more generally, in NB stage 4 diagnosed infants. Moreover, we propose that interference with the netrin-1 autocrine loop in malignant neuroblasts could represent an alternative therapeutic strategy, as disruption of this loop triggers in vitro NB cell death and inhibits NB metastasis in avian and mouse models.

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

Cited by 114 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3